Valley fever's mortality rate runs about one death per 1,000 infections, according to John Galgiani, MD, director of the Valley Fever Center for Excellence at the University of Arizona and professor of Internal Medicine with the College of Medicine – Phoenix. It doesn't need to be so high. To show that a vaccine could be effective protection against Coccidioides, Dr. Galgiani and his team started by focusing on an immunization for dogs with the infection. The canine vaccine he helped to develop has already proved itself. Dr. Galgiani believes that if funding allows, a human version of his vaccine could be ready for approval within eight years.
About the College
Founded in 2007, the University of Arizona College of Medicine – Phoenix inspires and trains exemplary physicians, scientists and leaders to optimize health and health care in Arizona and beyond. By cultivating collaborative research locally and globally, the college accelerates discovery in a number of critical areas — including cancer, stroke, traumatic brain injury and cardiovascular disease. Championed as a student-centric campus, the college has graduated more than 800 physicians, all of whom received exceptional training from nine clinical partners and more than 2,700 diverse faculty members. As the anchor to the Phoenix Bioscience Core, which is projected to have an economic impact of $3.1 billion by 2025, the college prides itself on engaging with the community, fostering education, inclusion, access and advocacy.